NSCLC Videos

Edward B. Garon, MD, MS, discusses second-line therapies for the treatment of patients with NSCLC.

Christine Ciunci, MD, MSCE, Penn Presbyterian Medical Center, spoke about the use of neoadjuvant versus adjuvant treatment in patients with early-stage NSCLC.

Dr Bauml talks about the use of brigatinib in the treatment of patients with ALK-positive NSCLC.

Dr Iyengar discusses the pros and cons of using proton therapy in the management of patients with stage III NSCLC.

Martin J. Edelman, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses the use of immunotherapy with or without chemo in the first-line treatment of NSCLC.

Jonathan Goldman, MD, discusses the role liquid biopsies play in the diagnosis and follow-up of patients with thoracic malignancies.

Lyudmila Bazhenova, MD, talks about understanding, preventing, and delaying EGFR-resistance in the era of osimertinib therapy.